{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:05Z","timestamp":1753891205222,"version":"3.41.2"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>MS is a chronic inflammatory and degenerative disease of the central nervous system (CNS) resulting in neurological deficits associated with physical and\/or cognitive disability. The gut microbiome can interact with the CNS and immune system through various molecular pathways and has been previously implicated in MS. Autologous Haematopoietic Stem Cell Transplant (AHSCT) in MS arrests inflammatory disease and has evidence of long-term therapeutic benefit. To date, no study has explored the effect of AHSCT on the gut microbiome in people with MS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>The microbiome of people with MS (pwMS) undergoing AHSCT was compared with pwMS on Natalizumab (NTZ). Longitudinal microbiome analysis was also conducted within the AHSCT cohort at two timepoints. Amplicon sequencing of the 16S ribosomal RNA V3\u20134 region (Illumina MiSeq) was used to evaluate alpha and beta diversity, oral-stool microbiota distances, and relative taxa abundances on both oral and stool microbiota.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The pre-transplant, baseline samples from the AHSCT cohort (n=8) was compared to the Natalizumab group (n=22). The AHSCT cohort had lower oral species richness compared to the NTZ cohort (p=0.026). There was a significant difference in oral beta diversity between the two cohorts (p=0.043). The oral taxa analysis of AHSCT subjects showed increased relative abundances of Porphyromonas and decreased Veillonella.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This pilot study identified specific microbiome changes, particularly in the oral alpha diversity and abundance of specific bacteria which may reflect treatment status or disease activity in MS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1590601","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:10:47Z","timestamp":1751256647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Jun","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeem O.","family":"Kaakoush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Massey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Danta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-12047-9","article-title":"Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study","volume":"271","author":"Habbestad","year":"2024","journal-title":"J Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2020-0292","article-title":"Clinical presentation and diagnosis of multiple sclerosis","volume":"20","author":"Ford","year":"2020","journal-title":"Clin Med (Lond)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3395","article-title":"Class II HLA interactions modulate genetic risk for multiple sclerosis","volume":"47","author":"Moutsianas","year":"2015","journal-title":"Nat Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","article-title":"The immunogenetics of multiple sclerosis: A comprehensive review","volume":"64","author":"Hollenbach","year":"2015","journal-title":"J Autoimmun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.04.007","article-title":"Microbial view of central nervous system autoimmunity","volume":"588","author":"Berer","year":"2014","journal-title":"FEBS Lett"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00410","article-title":"Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant","volume":"9","author":"Massey","year":"2018","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2018.11.005","article-title":"Microglia in central nervous system inflammation and multiple sclerosis pathology","volume":"25","author":"Voet","year":"2019","journal-title":"Trends Mol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101617","DOI":"10.1016\/j.bpg.2019.05.004","article-title":"Interfering with leukocyte trafficking in Crohn\u2019s disease","author":"Biswas","year":"2019","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200166","article-title":"Natalizumab treatment induces proinflammatory CD4 T cells preferentially in the integrin \u03b27+ Compartment","volume":"10","author":"Nguyen Ky","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.02.014","article-title":"Autologous hematopoietic cell transplantation for treatment-refractory relapsing multiple sclerosis: position statement from the american society for blood and marrow transplantation","volume":"25","author":"Cohen","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/nu13062099","article-title":"Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders","volume":"13","author":"Chen","year":"2021","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.neuron.2019.02.008","article-title":"Gut microbe to brain signaling: what happens in vagus\u2026","volume":"101","author":"F\u00fclling","year":"2019","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-022-00697-8","article-title":"The role of the gut microbiota in multiple sclerosis","volume":"18","author":"Correale","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/JIM.0000000000000192","article-title":"Gut microbiota in multiple sclerosis: possible influence of immunomodulators","volume":"63","author":"Cantarel","year":"2015","journal-title":"J Investig Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137429","article-title":"Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters","volume":"10","author":"Miyake","year":"2015","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"28484","DOI":"10.1038\/srep28484","article-title":"Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"12015","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1711233114","article-title":"Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice","volume":"114","author":"Berer","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","article-title":"Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course","volume":"185","author":"Zhou","year":"2022","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3069-8","article-title":"Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation","volume":"96","author":"Doki","year":"2017","journal-title":"Ann Hematol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01541-09","article-title":"Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities","volume":"75","author":"Schloss","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40168-022-01320-0","article-title":"A comprehensive evaluation of microbial differential abundance analysis methods: current status and potential solutions","volume":"10","author":"Yang","year":"2022","journal-title":"Microbiome"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.691016","article-title":"Porphyromonas gingivalis-induced neuroinflammation in Alzheimer\u2019s disease","volume":"15","author":"Olsen","year":"2021","journal-title":"Front Neurosci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.pmbts.2022.07.001","article-title":"Chapter Three - Gastrointestinal microbiome in the context of Helicobacter pylori infection in stomach and gastroduodenal diseases","volume":"192","author":"Retnakumar","year":"2022","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092211","article-title":"Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota","volume":"15","author":"Fusco","year":"2023","journal-title":"Nutrients"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnac072","article-title":"Roles of intestinal Parabacteroides in human health and diseases","volume":"369","author":"Cui","year":"2022","journal-title":"FEMS Microbiol Lett"},{"key":"B30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41368-022-00163-7","article-title":"Oral microbiota in human systematic diseases","volume":"14","author":"Peng","year":"2022","journal-title":"Int J Oral Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1038\/s41598-022-07336-8","article-title":"B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients","volume":"12","author":"Troci","year":"2022","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7786","DOI":"10.1038\/s41598-024-57949-4","article-title":"Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot study","volume":"14","author":"Boussamet","year":"2024","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260384","article-title":"Bacterial variation in the oral microbiota in multiple sclerosis patients","volume":"16","author":"Zangeneh","year":"2021","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.14196\/mjiri.31.62","article-title":"Study of Porphyromonas gingivalis in periodontal diseases: A systematic review and meta-analysis","volume":"31","author":"Rafiei","year":"2017","journal-title":"Med J Islam Repub Iran"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082331","article-title":"Intracellular porphyromonas gingivalis promotes the tumorigenic behavior of pancreatic carcinoma cells","volume":"12","author":"Gnanasekaran","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau3333","article-title":"Porphyromonas gingivalis in Alzheimer\u2019s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors","volume":"5","author":"Dominy","year":"2019","journal-title":"Sci Adv"},{"key":"B37","doi-asserted-by":"publisher","first-page":"15789","DOI":"10.1038\/s41598-017-16190-y","article-title":"Porphyromonas gingivalis lipopolysaccharides act exclusively through TLR4 with a resilience between mouse and human","volume":"7","author":"Nativel","year":"2017","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2002.73.5.511","article-title":"Effects of porphyromonas gingivalis on the central nervous system: activation of glial cells and exacerbation of experimental autoimmune encephalomyelitis","volume":"73","author":"Shapira","year":"2002","journal-title":"J Periodontol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12050333","article-title":"Classical and alternative activation of rat microglia treated with ultrapure porphyromonas gingivalis lipopolysaccharide in vitro","volume":"12","author":"Memedovski","year":"2020","journal-title":"Toxins (Basel)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"32762","DOI":"10.3402\/jom.v8.32762","article-title":"Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria","volume":"8","author":"Perera","year":"2016","journal-title":"J Oral Microbiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.895537","article-title":"The oral microbiota: community composition, influencing factors, pathogenesis, and interventions","volume":"13","author":"Li","year":"2022","journal-title":"Front Microbiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.721691","article-title":"Effects of antibiotic use on saliva antibody content and oral microbiota in sprague dawley rats","volume":"12","author":"Cheng","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"103798","DOI":"10.1016\/j.ebiom.2021.103798","article-title":"Alterations of host-gut microbiome interactions in multiple sclerosis","volume":"76","author":"Cantoni","year":"2022","journal-title":"EBioMedicine"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.590783","article-title":"Alterations of the fecal microbiota in chinese patients with multiple sclerosis","volume":"11","author":"Ling","year":"2020","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01390","article-title":"Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis","volume":"11","author":"Saresella","year":"2020","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2016-0130","article-title":"Roseburia spp.: A marker of health","volume":"12","author":"Tamanai-Shacoori","year":"2017","journal-title":"Future Microbiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1922241","DOI":"10.1080\/19490976.2021.1922241","article-title":"Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health","volume":"13","author":"Ezeji","year":"2021","journal-title":"Gut Microbes"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.05.003","article-title":"Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells","volume":"831","author":"Li","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"230014","DOI":"10.1098\/rsob.230014","article-title":"Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections","volume":"13","author":"Ney","year":"2023","journal-title":"Open Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10220","article-title":"Acetate correlates with disability and immune response in multiple sclerosis","volume":"8","author":"P\u00e9rez-P\u00e9rez","year":"2020","journal-title":"PeerJ"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2274126","DOI":"10.1080\/19490976.2023.2274126","article-title":"Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis","volume":"15","author":"Kujawa","year":"2023","journal-title":"Gut Microbes"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117519","article-title":"The pathophysiologic role of alpha 4 integrins in vivo","volume":"94","author":"Lobb","year":"1994","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation","volume":"382","author":"Peled","year":"2020","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Taur","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006923","article-title":"Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study","volume":"137","author":"Khan","year":"2021","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020026","article-title":"Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children","volume":"142","author":"Masetti","year":"2023","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40168-022-01270-7","article-title":"Linking gastrointestinal microbiota and metabolome dynamics to clinical outcomes in paediatric haematopoietic stem cell transplantation","volume":"10","author":"Vaitkute","year":"2022","journal-title":"Microbiome"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.200","article-title":"Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors","volume":"52","author":"Liu","year":"2017","journal-title":"Bone Marrow Transpl"},{"key":"B61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5534\/wjmh.190009","article-title":"Sex differences in gut microbiota","volume":"38","author":"Kim","year":"2020","journal-title":"World J Men\u2019s Health"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.1260","article-title":"Impact of antibiotics on the human microbiome and consequences for host health","volume":"11","author":"Patangia","year":"2022","journal-title":"MicrobiologyOpen"},{"key":"B63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12967-017-1175-y","article-title":"Influence of diet on the gut microbiome and implications for human health","volume":"15","author":"Singh","year":"2017","journal-title":"J Transl Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1590601\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:10:48Z","timestamp":1751256648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1590601\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":63,"alternative-id":["10.3389\/fimmu.2025.1590601"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1590601","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"article-number":"1590601"}}